935 related articles for article (PubMed ID: 17548248)
1. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
[TBL] [Abstract][Full Text] [Related]
3. Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: a randomised trial.
Kirchhoff TD; Rudolph KL; Layer G; Chavan A; Greten TF; Rosenthal H; Kubicka S; Galanski M; Manns MP; Schild H; Gallkowski U
Eur J Surg Oncol; 2006 Mar; 32(2):201-7. PubMed ID: 16373084
[TBL] [Abstract][Full Text] [Related]
4. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
[TBL] [Abstract][Full Text] [Related]
7. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
8. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
10. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
11. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
[TBL] [Abstract][Full Text] [Related]
12. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
[TBL] [Abstract][Full Text] [Related]
14. [Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study].
Kawai S; Tani M; Mikuriya S; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Jinno K; Makino M; Oda T
Gan To Kagaku Ryoho; 1990 Feb; 17(2):227-32. PubMed ID: 2154160
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
16. [Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma].
Horikiri N; Yamakado K; Nakatsuka A; Ishii T; Matsushima N; Tanaka N; Takeda K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1493-6. PubMed ID: 11707962
[TBL] [Abstract][Full Text] [Related]
17. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
[TBL] [Abstract][Full Text] [Related]
19. Chemoembolization in liver malignant involvement. Experiences on 17 cases.
Fiorentini G; Campanini A; Dazzi C; Davitti B; Graziani G; Priori T; Ricci Bitti R; Angelini L
Minerva Chir; 1994 Apr; 49(4):281-5. PubMed ID: 8072703
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
